Breadcrumb
- Home
- Publications
- Proceedings
- 2025 AIChE Annual Meeting
- Food, Pharmaceutical & Bioengineering Division
- Advances in Biosensing for Diagnostic Applications
- (22a) Controlling TIMP-MMP Protein-Protein Interaction By Photoactivation
In one study, we used Dronpa-based photoswitchable protein fusion systems to control the interaction between tissue inhibitors of metalloproteinases (TIMP) and matrix metalloproteinases (MMPs). Dronpa was fused to either the N- or C-terminus of N-TIMP-1 (the N-terminal domain of TIMP-1) and expressed on the yeast surface as a fusion with Aga2 (a yeast surface protein), or in solution. Upon exposure to light, Dronpa oligomerization limited the binding of TIMP-1 to its target MMPs at both fusion sites. However, placing Dronpa at the N-terminus of N-TIMP-1 disrupted its inhibitory function, while the N-TIMP-Dronpa fusion was able to reversibly inhibit the MMP-3 catalytic domain. This was demonstrated through tight inhibitor assays using a plate reader. This light-controlled system offers a powerful method for studying dynamic cellular processes by enabling the activation or deactivation of specific protein functions with high spatial and temporal precision. Protein caging with Dronpa applies to various areas, such as signaling pathway modulation, drug delivery, bioimaging, and protein-protein interaction studies, thereby enhancing our understanding of complex biological networks.